Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  In Analysis

• Publication date

  2014-08-11

• Fields of study

  Materials Science, Medicine, Physics, Engineering

• Identifiers
  DOI 10.1039/c4an00990hPMID 25054827PMCID PMC4139704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRI at 7 tesla and above: Demonstrated and potential capabilities

  2015cited by this paper
• Spin crossover iron(II) complexes as PARACEST MRI thermometers

  2014cited by this paper
• Seven-Coordinate CoII, FeII and Six-Coordinate NiII Amide-Appended Macrocyclic Complexes as ParaCEST Agents in Biological Media

  2014cited by this paper
• Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications.

  2014cited by this paper
• Lanthanide probes for bioresponsive imaging.

  2014cited by this paper
• Polymeric nanoparticles for molecular imaging.

  2014cited by this paper
• Diffusion properties of conventional and calcium-sensitive MRI contrast agents in the rat cerebral cortex.

  2014cited by this paper
• Comparison of divalent transition metal ion paraCEST MRI contrast agents

  2014cited by this paper
• Detection of in vivo enzyme activity with CatalyCEST MRI

  2014cited by this paper
• Functionalized nanomaterials: their use as contrast agents in bioimaging: mono- and multimodal approaches

  2013cited by this paper
• Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.

  2013cited by this paper
• A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond.

  2013cited by this paper
• Nanoparticle‐based chemical exchange saturation transfer (CEST) agents

  2013cited by this paper
• Modulation of CEST images in vivo by T1 relaxation: a new approach in the design of responsive PARACEST agents.

  2013cited by this paper
• Electrochemical Study of the EuIII/EuII Redox Properties of Complexes with Potential MRI Ligands

  2013cited by this paper
• Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression.

  2013cited by this paper
• Boosting 19F MRI—SNR efficient detection of paramagnetic contrast agents using ultrafast sequences

  2013cited by this paper
• CEST: from basic principles to applications, challenges and opportunities.

  2013cited by this paper
• Clinical applications of 7 T MRI in the brain.

  2013cited by this paper
• CoCEST: cobalt(II) amide-appended paraCEST MRI contrast agents.

  2013cited by this paper
• Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.

  2013cited by this paper
• In vivo MRI visualization of different cell populations labeled with PARACEST agents

  2013cited by this paper
• Nuts and bolts of chemical exchange saturation transfer MRI

  2013cited by this paper
• Salicylic acid and analogues as diaCEST MRI contrast agents with highly shifted exchangeable proton frequencies.

  2013cited by this paper
• Application of Chemical Exchange Saturation Transfer (CEST) MRI for Endogenous Contrast at 7 Tesla

  2013cited by this paper
• In vivo MRI cell tracking using perfluorocarbon probes and fluorine‐19 detection

  2013cited by this paper
• Synthesis and characterization of a novel gadolinium-based contrast agent for magnetic resonance imaging of myelination.

  2013cited by this paper
• Metal ion sensing using ion chemical exchange saturation transfer 19F magnetic resonance imaging.

  2013cited by this paper
• Lanthanide(III) complexes of aminoethyl-DO3A as PARACEST contrast agents based on decoordination of the weakly bound amino group.

  2013cited by this paper
• Characterisation and evaluation of paramagnetic fluorine labelled glycol chitosan conjugates for 19F and 1H magnetic resonance imaging

  2013cited by this paper
• Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.

  2013cited by this paper
• A redox-activated MRI contrast agent that switches between paramagnetic and diamagnetic states.

  2013cited by this paper
• Effect of r₁ and r₂ relaxivity of gadolinium-based contrast agents on the T₁-weighted MR signal at increasing magnetic field strengths.

  2013cited by this paper
• 19F MRI Monitoring of Gene Expression in Living Cells through Cell‐Surface β‐Lactamase Activity

  2012cited by this paper
• The NiCEST approach: nickel(II) paraCEST MRI contrast agents.

  2012cited by this paper
• PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities.

  2012cited by this paper
• ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.

  2012cited by this paper
• Analytical methods for characterizing magnetic resonance probes.

  2012cited by this paper
• Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.

  2012cited by this paper
• Physical Properties of Eu(2+)-Containing Cryptates as Contrast Agents for Ultra-High Field Magnetic Resonance Imaging.

  2012cited by this paper
• Improved pH measurements with a single PARACEST MRI contrast agent.

  2012cited by this paper
• Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

  2012cited by this paper
• Paramagnetic 19F chemical shift probes that respond selectively to calcium or citrate levels and signal ester hydrolysis.

  2012cited by this paper
• Structure - relaxivity relationships among targeted MR contrast agents.

  2012cited by this paper
• 7‐T MR—from research to clinical applications?

  2012cited by this paper
• Paramagnetic nanoparticle T1 and T2 MRI contrast agents.

  2012cited by this paper
• Bioengineered probes for molecular magnetic resonance imaging in the nervous system.

  2012cited by this paper
• Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.

  2012cited by this paper
• Iron(II) complexes containing octadentate tetraazamacrocycles as paraCEST magnetic resonance imaging contrast agents.

  2012cited by this paper
• Developments in the Coordination Chemistry of Europium(II).

  2012cited by this paper
• Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging.

  2012cited by this paper
• Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

  2012cited by this paper
• DOTAM-type ligands possessing arginine pendant groups for use in PARACEST MRI.

  2012cited by this paper
• Nanotechnology Reviews

  2012cited by this paper
• The future of ultra-high field MRI and fMRI for study of the human brain

  2012cited by this paper
• Characterization of nanoparticle-based contrast agents for molecular magnetic resonance imaging

  2012cited by this paper
• Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

  2011cited by this paper
• Iron(II) PARACEST MRI contrast agents.

  2011cited by this paper
• Clinical fMRI: Evidence for a 7 T benefit over 3 T

  2011cited by this paper
• Calcium-responsive paramagnetic CEST agents.

  2011cited by this paper
• A lanthanide complex with dual biosensing properties: CEST (chemical exchange saturation transfer) and BIRDS (biosensor imaging of redundant deviation in shifts) with europium DOTA–tetraglycinate

  2011cited by this paper
• Overcoming the Low Relaxivity of Gadofosveset at High Field with Spin Locking

  2011cited by this paper
• Fluorine (19F) MRS and MRI in biomedicine

  2011cited by this paper
• Activatable T1 and T2 Magnetic Resonance Imaging Contrast Agents

  2011cited by this paper
• Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes.

  2011cited by this paper
• An aryl-phosphonate appended macrocyclic platform for lanthanide based bimodal imaging agents.

  2011cited by this paper
• A myelin-specific contrast agent for magnetic resonance imaging of myelination.

  2011cited by this paper
• Gold nanocages as contrast agents for photoacoustic imaging.

  2011cited by this paper
• Chemical exchange saturation transfer (CEST): What is in a name and what isn't?

  2011cited by this paper
• Eu(III) complexes as anion-responsive luminescent sensors and paramagnetic chemical exchange saturation transfer agents.

  2011cited by this paper
• Development of Intravascular Contrast Agents for MRI Using Gadolinium Chelates

  2011cited by this paper
• Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance.

  2011cited by this paper
• 19F‐lanthanide complexes with increased sensitivity for 19F‐MRI: Optimization of the MR acquisition

  2011cited by this paper
• Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents.

  2011cited by this paper
• 19F MRI detection of β-galactosidase activity for imaging of gene expression

  2011cited by this paper
• A modular system for the synthesis of multiplexed magnetic resonance probes.

  2011cited by this paper
• Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.

  2010cited by this paper
• Challenges for molecular magnetic resonance imaging.

  2010cited by this paper
• Quantitative magnetic resonance fluorine imaging: today and tomorrow.

  2010cited by this paper
• Oxidatively stable, aqueous europium(II) complexes through steric and electronic manipulation of cryptand coordination chemistry.

  2010cited by this paper
• (19)F MRI for quantitative in vivo cell tracking.

  2010cited by this paper
• A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.

  2010cited by this paper
• Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

  2010cited by this paper
• Ultra-high-field magnetic resonance: Why and when?

  2010cited by this paper
• Gadolinium-Based Magnetic Resonance Contrast Agents at 7 Tesla: In Vitro T1 Relaxivities in Human Blood Plasma

  2010cited by this paper
• Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters.

  2010cited by this paper
• Imaging of adult astrocytic brain tumours with 7 T MRI: preliminary results

  2010cited by this paper
• Manipulation of tissue contrast using contrast agents for enhanced MR microscopy in ex vivo mouse brain

  2009cited by this paper
• Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.

  2009cited by this paper
• First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T

  2009cited by this paper
• Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

  2009cited by this paper
• Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths

  2005cited by this paper
• EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents.

  2002cited by this paper
• Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine.

  2001cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Chemistry of the elements

  1984cited by this paper
• Macromolecules.

  1976cited by this paper

• Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.

  2022cites this paper
• Optimizing the relaxivity at high fields: systematic variation of the rotational dynamics in polynuclear Gd-complexes based on the AAZTA ligand

  2021cites this paper
• Water-Nanomaterial Interaction to Escalate Twin-Mode Magnetic Resonance Imaging.

  2020cites this paper
• Shape-controlled MnO nanoparticles as T1 MRI contrast agents

  2019cites this paper
• The Transition from Metal-Based to Metal-Free Contrast Agents for T1 Magnetic Resonance Imaging Enhancement.

  2019cites this paper
• Metal-based redox-responsive MRI contrast agents

  2019cites this paper
• Gadolinum-gold core-shell nanocrystals: Potential contrast agents for molecular MRI with high T1 relaxivity

  2018cites this paper
• Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications

  2018cites this paper
• Editorial: The Chemistry of Imaging Probes

  2018cites this paper
• Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

  2018cites this paper
• Filling Tricompartmental Ligands with GdIII and ZnII Ions: Some Structural and MRI Studies

  2018influential citation
• Localizing the Nanodeformation Impact of Magnetic Nanoparticles on Macromolecular Objects by Physical and Biochemical Means

  2018cites this paper
• The dynamics of magnetic nanoparticles exposed to non-heating alternating magnetic field in biochemical applications: theoretical study

  2017cites this paper
• Dual contrast microvascular MRI

  2016cites this paper
• Water-soluble tetraaqua Ln(III) glycinehydroximate 15-metallacrown-5 complexes towards potential MRI contrast agents for ultra-high magnetic field

  2016cites this paper
• Aqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging

  2016cites this paper
• Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging.

  2015cites this paper
• Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI

  2015cites this paper
• Matrix-Assisted Ionization-Ion Mobility Spectrometry-Mass Spectrometry: Selective Analysis of a Europium–PEG Complex in a Crude Mixture

  2015cites this paper